Search fresh public links, source activity, and post angles for Saha 2026.
Fresh curated links around SAHA 2026 are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
May 28 2026 - AbbVie snags FDA’s first ADC approval for ultra-rare blood cancer admin Thu, 05/28/2026 - 11:51 Steady progress across the board today, with new appro...
Image source: The Motley Fool. DateWednesday, May 6, 2026 at 8:30 a.m. ETCall participantsChief Executive Officer — Sean NolanPresident and Head of R&D — Sukumar NagendranChie...
Image source: The Motley Fool. DateWednesday, May 6, 2026 at 8:30 a.m. ETCall participantsChief Executive Officer — Sean NolanPresident and Head of R&D — Sukumar NagendranChie...
May 11 2026 - FDA mulls repurposing approved drugs to expand access admin Mon, 05/11/2026 - 11:47 From FDA policy signals to big strategic goals, today’s headlines...
April 23 2026 - Unnamed pharma files citizen petition targeting FDA’s trove of rejection letters admin Thu, 04/23/2026 - 11:43 Regulatory questions lead the day, wi...
The International Hospital Federation is accepting nominations for its 2026 awards through April 24. The IHF Awards honor excellence in hospitals and health care organizat...
AACR 2026 saw thousands gathered in San Diego, California, where major progress in cancer research was revealed. The post AACR 2026: where is cancer therapeutics heading? appeared...
On March 30, 2026, Teva announced that the FDA and the European Medicines Agency (EMA) accepted regulatory submissions for its proposed biosimilar to Xolair® (omalizumab), TEV-4577...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.